» Articles » PMID: 36005158

Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy After Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2022 Aug 25
PMID 36005158
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Total pancreatectomy (TP) can be performed in cases with positive resection margin after partial pancreatectomy for pancreatic cancer. However, despite complete removal of the residual pancreatic parenchyme, it is questionable whether an actual R0 resection and favorable survival can be achieved. This study aimed to identify the R0 resection rate and postoperative outcomes, including survival, following completion TP (cTP) performed due to intraoperative positive margin.

Methods: From 1995 to 2015, 1096 patients with pancreatic ductal adenocarcinoma underwent elective pancreatectomy at the Samsung Medical Center. Among these, 25 patients underwent cTP, which was converted during partial pancreatectomy because of a positive resection margin. To compare survival after R0 resection between the cTP R0 and pancreaticoduodenectomy (PD) R0 cases, propensity score matching was conducted to balance the baseline characteristics.

Results: The R0 rate of cTP performed due to intraoperative positive margin was 84% (21/25). The overall 5-year survival rate (5YSR) in the 25 cTP cases was 8%. There was no difference in the 5YSR between the cTP R0 and cTP R1 groups (9.5% versus 0.0%, = 0.963). However, the 5YSR of the cTP R0 group was significantly lower than that of the PD R0 group (9.5% versus 20.0%, = 0.022). There was no distinct difference in postoperative complications between the cTP R0 versus cTP R1 and cTP R0 versus PD R0 groups.

Conclusions: In cases with intraoperative positive pancreatic parenchymal resection margin, survival after cTP was not favorable. Careful patient selection is needed to perform cTP in such cases.

Citing Articles

Intraoperative liquid biopsy as a tool for detecting R1 resection during pancreatoduodenectomy in patients with pancreatic carcinoma: the CETUPANC trial (part II).

Padillo-Ruiz J, Garcia C, Suarez G, Blanco G, Munoz-Bellvis L, Justo I Int J Surg. 2025; 110(12):7798-7805.

PMID: 39806742 PMC: 11634100. DOI: 10.1097/JS9.0000000000002153.


Computed tomography-based radiomics and body composition analysis for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy.

Wu H, Yu D, Li J, He X, Li C, Li S Gland Surg. 2024; 13(9):1588-1604.

PMID: 39421053 PMC: 11480874. DOI: 10.21037/gs-24-167.

References
1.
Casadei R, Monari F, Buscemi S, Laterza M, Ricci C, Rega D . Total pancreatectomy: indications, operative technique, and results: a single centre experience and review of literature. Updates Surg. 2010; 62(1):41-6. DOI: 10.1007/s13304-010-0005-z. View

2.
Tempero M, Malafa M, Al-Hawary M, Asbun H, Bain A, Behrman S . Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017; 15(8):1028-1061. DOI: 10.6004/jnccn.2017.0131. View

3.
Petrucciani N, Nigri G, Giannini G, Sborlini E, Antolino L, DeAngelis N . Total Pancreatectomy for Pancreatic Carcinoma: When, Why, and What Are the Outcomes? Results of a Systematic Review. Pancreas. 2020; 49(2):175-180. DOI: 10.1097/MPA.0000000000001474. View

4.
Muller M, Friess H, Kleeff J, Dahmen R, Wagner M, Hinz U . Is there still a role for total pancreatectomy?. Ann Surg. 2007; 246(6):966-74. DOI: 10.1097/SLA.0b013e31815c2ca3. View

5.
Hirai I, Kimura W, Ozawa K, Kudo S, Suto K, Kuzu H . Perineural invasion in pancreatic cancer. Pancreas. 2001; 24(1):15-25. DOI: 10.1097/00006676-200201000-00003. View